pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,053 catalysts · 3,603 8k filing · 2,283 grant · 1,771 approval · 1,164 device 510k · 1,000 device adverse event · 848 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: approval×type: recall×from 2025-12-03×clear all
type
  • 8k filing3,603
  • grant2,283
  • approval1,771
  • device 510k1,164
  • device adverse event1,000
  • device pma848
device recall
635
  • earnings585
  • recall282
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Dec 1, 2025

    41
    ›Dec 3, 2025approval269d agoERTUGLIFLOZIN — FDA approvalERTUGLIFLOZIN

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →ERTUGLIFLOZIN →fda approvals ↗
    ›Dec 3, 2025approval269d agoMACITENTAN — FDA approvalJOHNSON & JOHNSON

    Sponsor: SEASONS BIOTECH. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 3, 2025approval269d agoMACITENTAN — FDA approvalMACITENTAN

    Sponsor: MYLAN. Form: TABLET. Route: ORAL

    full page →MACITENTAN →fda approvals ↗
    ›Dec 3, 2025approval269d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: TORRENT. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Karina Daily Moisturizer SPF 25, Octinoxate 7.5% and Zinc Oxide 7.0%, Net WT. 5 oz/ 141.7 g per tube, Dist. By: Beauty4Pros LLC, Palm Desert, CA 92211. NDC: 35192-033-16, UPC 8 18204 02572 5 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Elixir by Coco March Tinted Mineral Sunscreen SPF 50, Zinc Oxide 21%, 2.1 oz (62g) per bottle, Distributed by: VitaTienda Co U.S.A., San Juan, PR 00646. NDC: 35192-050-17, UPC 6 7229 99913 8 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Sugared+Bronzed Tinted Mineral Sunscreen SPF 50, Zinc Oxide 21%, Net WT 3.3 OZ (93 G) per tube, Dist. By: Sugared+Bronzed, 929 Montana Ave, Santa Monica, CA 90403. NDC: 35192-055-18, UPC 8 50047 92223 6 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Doctor D. Schwab Controlling Cream, Benzoyl Peroxide 2.7%, 1 FL OZ/ 30 ML per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92123. NDC: 35192-017-05 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoFresenius Kabi USA, LLC recall (Cls I)Fresenius Kabi USA LLC

    Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale). — Reason: Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Doctor D. Schwab Controlling Balm with Tea Tree Oil, Salicyclic Acid 0.8%, 1 FL OZ/ 30 ML per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92123. NDC: 35192-016-05 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Doctor D. Schwab Shimmery Sun Lotion Sunscreen SPF 30, Titanium Dioxide 5% and Octinoxate 4%, 4 oz./113.4 g per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92121. NDC: 35192-012-02 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Doctor. D. Schwab Mineral Sunscreen SPF 50, Zinc Oxide 21%, 4 oz./ 113.4 g per tube, Manufactured by CA Botana, San Diego, CA 92123. NDC: 35192-042-02 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    CLEARSTEM YOU ARE SUNSHINE SPF 50, Zinc Oxide 21%, 2.1 oz/61g per bottle, Distributed by: CLEARSTEM Skincare, clearstemskincare.com. NDC: 35192-046-17 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Doctor D. Schwab Clinical Weh Weh Natural Pain Relief Gel with Menthol and Arnica, Menthol 5%, 4.2 oz./120 g per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92121. NDC: 35192-020-02 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Sea Enzyme Ultra Umbrella Sunscreen SPF 30, Titanium Dioxide 4%, Octinoxate 4%, 4 oz./113.4 g per tube, Manufactured by CA BOTANA, San Diego, CA 92121. NDC: 35192-011-02 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Elixir by Coco March Mineral Sunscreen SPF 50, Zinc Oxide 21%, 2.1 oz (62g) per bottle, Distributed by: VitaTienda Co U.S.A., San Juan, PR 00646. NDC: 35192-048-17, UPC 8 10145 82007 0 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Doctor D. Schwab Flawless Skin Fluid Tinted Moisturizer SPF 50, Zinc Oxide 21%, 2.1 oz/61 g per tube, Manufactured by CA BOTANA, San Diego, CA 92121. NDC: 35192-043-17 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Gabriel Mineral Sunscreen SPF 50, Zinc Oxide 21%, 2.1 oz, Net 61 g per tube, Dist. By: Gabriel Cosmetics, Inc., Redmond, WA USA 98052, NDC: 35192-044-01, UPC 7 07060 9592 1 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoMedical Products Laboratories, Inc. recall (Cls II)Revalesio Corp

    Walgreens Saline Nasal Spray WITH XYLITOL, 1.5 oz (45mL) bottle, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD., DEERFIELD, IL 60015, NDC 0363-3114-01 — Reason: Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 3, 2025recall269d agoCA BOTANA International, Inc. recall (Cls II)CRA INTERNATIONAL, INC.

    Dr. Bump Natural Pain Relief Gel, Menthol 5%, NET WT 4 FL OZ/118 ML per bottle, Distr. by 1Beauty US LLC, Palm Desert, CA 92211. NDC: 35192-052-18, UPC 8 18204 02513 8 — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 4, 2025approval268d agoEPLERENONE — FDA approvalEPLERENONE

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →EPLERENONE →fda approvals ↗
    ›Dec 4, 2025approval268d agoTOPIRAMATE — FDA approvaltopiramate ER

    Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL

    full page →topiramate ER →fda approvals ↗
    ›Dec 5, 2025approval267d agoONTRUZANT (TRASTUZUMAB-DTTB) — FDA approvalONTRUZANT

    Sponsor: SAMSUNG BIOEPIS CO LTD. Form: POWDER. Route: IV (INFUSION)

    full page →ONTRUZANT →fda approvals ↗
    ›Dec 5, 2025approval267d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 5, 2025approval267d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 5, 2025approval267d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 5, 2025approval267d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 5, 2025approval267d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 5, 2025approval267d agoOXYCODONE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: HIBROW HLTHCARE. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 5, 2025approval267d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: GRANULES. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 5, 2025approval267d agoACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approvalEon Labs Inc

    Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 5, 2025approval267d agoACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: CHARTWELL. Form: SOLUTION. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 5, 2025approval267d agoOXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: PH HEALTH. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 5, 2025approval267d agoRIFADIN (RIFAMPIN) — FDA approvalRIFADIN

    Sponsor: SANOFI AVENTIS US. Form: INJECTABLE. Route: INJECTION

    full page →RIFADIN →fda approvals ↗
    ›Dec 5, 2025approval267d agoRIFATER (ISONIAZID) — FDA approvalRIFATER

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →RIFATER →fda approvals ↗
    ›Dec 5, 2025approval267d agoILLUCCIX (GALLIUM GA-68 GOZETOTIDE) — FDA approvalILLUCCIX

    Sponsor: TELIX. Form: POWDER. Route: INTRAVENOUS

    full page →ILLUCCIX →fda approvals ↗
    ›Dec 5, 2025approval267d agoRIFADIN (RIFAMPIN) — FDA approvalRIFADIN

    Sponsor: SANOFI AVENTIS US. Form: CAPSULE. Route: ORAL

    full page →RIFADIN →fda approvals ↗
    ›Dec 5, 2025approval267d agoETICOVO (ETANERCEPT-YKRO) — FDA approvalETICOVO

    Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION

    full page →ETICOVO →fda approvals ↗
    ›Dec 5, 2025approval267d agoAMANTADINE HYDROCHLORIDE — FDA approvalShinkei Therapeutics LLC

    Sponsor: SHREE HARI INTL. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›Dec 5, 2025approval267d agoACETAMINOPHEN — FDA approvalIGC Pharma, Inc.

    Sponsor: CAPLIN. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Dec 5, 2025approval267d agoARIKAYCE KIT (AMIKACIN SULFATE) — FDA approvalamikacin sulfate PR

    Sponsor: INSMED INC. Form: SUSPENSION, LIPOSOMAL. Route: INHALATION

    full page →amikacin sulfate PR →fda approvals ↗

    Week of Dec 8, 2025

    9
    ›Dec 8, 2025approval264d agoWINREVAIR (SOTATERCEPT-CSRK) — FDA approvalsotatercept

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →sotatercept →fda approvals ↗
    ›Dec 8, 2025approval
    ← prev
    page 1 of 42
    next →
    264d ago
    HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: LANNETT CO INC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 8, 2025approval264d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: LANNETT CO INC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 8, 2025approval264d agoEPINEPHRINE — FDA approvaladrenaline

    Sponsor: AMNEAL. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →adrenaline →fda approvals ↗
    ›Dec 8, 2025approval264d agoLINEZOLID — FDA approvalHQ Speciality Pharma

    Sponsor: CAPLIN. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Dec 8, 2025approval264d agoESTRADIOL — FDA approvalestradiol ER

    Sponsor: TEVA PHARMS USA INC. Form: INSERT. Route: VAGINAL

    full page →estradiol ER →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Dec 9, 2025approval263d agoOXYCODONE HYDROCHLORIDE — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $JNJ268.04+0.85%
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $CRAI172.50+1.06%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $CRAI172.50+1.06%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $IGC0.2670+0.41%
    $INSM121.91-1.99%
    $TLX
    $ANIP73.85-0.95%
    $AMRX17.54-2.61%
    $ANIP73.85-0.95%
    $AMRX17.54-2.61%
    $ANIP73.85-0.95%